Healthcare & Medical Devices Global On demand · 24-48h

Global Program-Controlled Cooling Device Market Strategic Research Report

Global Program-Controlled Cooling Device Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Program-Controlled Cooling Device Market
$0B2024
0%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Small Capacity (<20 L), Medium Capacity (20-30 L), High Capacity (>30 L)

By Application: Research, Cell and Gene Therapy, Biobank, Others

Key Players: Strex, BioLife Solutions, Cytiva, Dohmeyer, Planer, Thermo Fisher Scientific, SP Industries, PHC Group, ESCO Lifesciences

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2024 · forecast to 2032
Length: 100 pages

Overzicht

Scope of the Report

The global Program-Controlled Cooling Device market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Most biological samples can be preserved long-term in liquid nitrogen. However, during the preparation phase before transferring the samples to liquid nitrogen, viable biological samples undergo a complex freezing phase transition process. Controlling the appropriate temperature gradient and freezing rate is crucial for maintaining cell viability. For various sensitive cells, such as protozoa, mammalian cells, and plant cells, it is necessary to precisely control the freezing rate at different cooling intervals. This is because factors such as intracellular heat release at the supercooling point, the formation of large ice crystals due to a too-fast freezing rate, and excessive dehydration of cells during a prolonged cooling process, are all detrimental to cell survival. A programmable freezer is a high-performance, safe, and reliable freezing system with adjustable temperature change rates. It features an upgraded touch screen interface, making it more user-friendly and simplifying the editing and use of freezing programs. It better meets the application needs in cutting-edge fields such as basic biological research, cell therapy, biopharmaceutical production, and biobanking.

Global key Program-Controlled Cooling Device players cover Strex, BioLife Solutions, Cytiva, Dohmeyer, Planer, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Program-Controlled Cooling Device market?

What factors are driving Program-Controlled Cooling Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Program-Controlled Cooling Device market opportunities vary by end market size?

How does Program-Controlled Cooling Device break out by Type, by Application?

This report presents a comprehensive overview of the global Program-Controlled Cooling Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Small Capacity (<20 L)
  • Medium Capacity (20-30 L)
  • High Capacity (>30 L)

Segment by Application

  • Research
  • Cell and Gene Therapy
  • Biobank
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Program-Controlled Cooling Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Research, Cell and Gene Therapy, Biobank evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type
Small Capacity (<20 L)Medium Capacity (20-30 L)High Capacity (>30 L)
By Application
ResearchCell and Gene TherapyBiobankOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Small Capacity (<20 L)
  • 3.1.3 Medium Capacity (20-30 L)
  • 3.1.4 High Capacity (>30 L)
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Research
  • 4.1.3 Cell and Gene Therapy
  • 4.1.4 Biobank
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Strex
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 BioLife Solutions
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cytiva
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Dohmeyer
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Planer
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Thermo Fisher Scientific
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SP Industries
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 PHC Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 ESCO Lifesciences
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What does the Program-Controlled Cooling Device market cover?
Most biological samples can be preserved long-term in liquid nitrogen. However, during the preparation phase before transferring the samples to liquid nitrogen, viable biological samples undergo a complex freezing phase transition process. Controlling the appropriate temperature gradient and freezing rate is crucial for maintaining cell viability.
What are the main segments of the Program-Controlled Cooling Device market by type?
By type, the market is segmented into Small Capacity (<20 L), Medium Capacity (20-30 L) and High Capacity (>30 L).
Which applications drive demand in the Program-Controlled Cooling Device market?
Key applications covered include Research, Cell and Gene Therapy, Biobank and Others.
Who are the key players in the Program-Controlled Cooling Device market?
Key players profiled include Strex, BioLife Solutions, Cytiva, Dohmeyer, Planer, Thermo Fisher Scientific, SP Industries and PHC Group, among 9 companies covered in total.
Which regions and countries are covered for Program-Controlled Cooling Device?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Program-Controlled Cooling Device market?
What factors are driving Program-Controlled Cooling Device market growth, globally and by region?
Who should buy the Program-Controlled Cooling Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Research, Cell and Gene Therapy and Biobank, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Program-Controlled Cooling Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.